Quoi de neuf pour le traitement de l'hépatite B [What's new in the treatment of hepatitis B infection?]

Détails

ID Serval
serval:BIB_09970C038C94
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Quoi de neuf pour le traitement de l'hépatite B [What's new in the treatment of hepatitis B infection?]
Périodique
Revue Médicale Suisse
Auteur(s)
Bihl F., Alaei M., Girardin M., Negro F.
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2009
Volume
5
Numéro
215
Pages
1720-1722, 1724
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Résumé
Although the number of available antiviral drugs for hepatitis B infection (VHB) today is higher than ever, treatment of chronic VHB infection is still often managed by specialists because of the complex natural history of this viral infection and of the risk of selecting viral strains that are resistant to therapy. Different clinical and virological aspects need to be considered to establish a correct indication for therapy. Once antiviral therapy has been started, patients need close monitoring to guarantee adequate compliance and to detect promptly the selection of viral variants resisting to therapy.
Mots-clé
Antiviral Agents/therapeutic use, Drug Resistance, Viral, Hepatitis B/drug therapy, Humans
Pubmed
Création de la notice
11/02/2010 17:57
Dernière modification de la notice
03/03/2018 13:32
Données d'usage